393 results on '"Chu, Chia-Ming"'
Search Results
2. Natural History of Hepatitis B Virus Infection
3. Letter to the Editor: Letter regarding "The long-term prognosis and the need for histologic assessment in chronic hepatitis B in serological immune-tolerant phase"
4. Hepatocyte expression of hepatitis B surface and core antigens across phases of chronic hepatitis B infection
5. Decreasing Levels of HBsAg Predict HBsAg Seroclearance in Patients With Inactive Chronic Hepatitis B Virus Infection
6. Level of Hepatitis B Virus DNA in Inactive Carriers With Persistently Normal Levels of Alanine Aminotransferase
7. Hepatitis B virus infection
8. Clinical and Virological Characteristics Post HBsAg Seroclearance in Hepatitis B Virus Carriers With Hepatic Steatosis Versus Those Without
9. Emergence of an S Gene Mutant during Thymosin α₁ Therapy in a Patient with Chronic Hepatitis B
10. Viral Load, Genotypes, and Mutants in Hepatitis B Virus-Related Hepatocellular Carcinoma: Special Emphasis on Patients with Early Hepatocellular Carcinoma
11. Immunopathology on Hepatocyte Expression of HBV Surface, Core, and x Antigens in Chronic Hepatitis B: Clinical and Virological Correlation
12. Comparative Studies on Expression of α-Smooth Muscle Actin in Hepatic Stellate Cells in Chronic Hepatitis B and C
13. Off-therapy durability of response to entecavir therapy in hepatitis B e antigen-negative chronic hepatitis B patients
14. Spontaneous relapse of hepatitis in inactive HBsAg carriers
15. Natural course following the onset of cirrhosis in patients with chronic hepatitis B: a long-term follow-up study
16. Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma
17. Natural Course of Chronic Hepatitis B Virus Infection
18. Identification and characterization of a prevalent hepatitis B virus X protein mutant in Taiwanese patients with hepatocellular carcinoma
19. Age-Specific Prognosis Following Spontaneous Hepatitis B E Antigen Seroconversion in Chronic Hepatitis B
20. Incidence and Risk Factors of Progression to Cirrhosis in Inactive Carriers of Hepatitis B Virus
21. Genotype C hepatitis B virus infection is associated with a higher risk of reactivation of hepatitis B and progression to cirrhosis than genotype B: A longitudinal study of hepatitis B e antigen-positive patients with normal aminotransferase levels at baseline
22. Reply
23. Percutaneous tumor ablation or surgical resection for small hepatocellular carcinoma?
24. HBsAg seroclearance in asymptomatic carriers of high endemic areas: Appreciably high rates during a long-term follow-up
25. Serum levels of interferon-α and-γ in acute and chronic hepatitis B virus infection
26. Prevalence and prognostic significance of bacterascites in cirrhosis with ascites
27. Immunoglobulin class M anti-hepatitis B core antigen for serodiagnosis of acute hepatitis: Pitfalls and recommendations
28. Hepatitis B Virus-Related Cirrhosis: Natural History and Treatment
29. Role of hepatitis B genotype in the natural course following development of cirrhosis: 84
30. Interferon therapy reduces cirrhosis and hepatocellular carcinoma in HBeAg positive chronic hepatitis: 62
31. Hepatic steatosis is the sequel of oxidative stress elicited by HCV core protein: studies in vitro and in a conditionally transgenic mouse line: 4
32. Secondary prevention of hepatitis C virus-related hepatocellular carcinoma
33. Hepatitis C virus infection facilitates gallstone formation
34. Impact of acute hepatitis C virus superinfection in patients with chronic hepatitis B virus infection
35. Natural history of hepatitis b e antigen to antibody seroconversion in patients with normal serum aminotransferase levels
36. Identification of a novel pre-S2 mutation in a subgroup of chronic carriers with spontaneous clearance of hepatitis B virus surface antigen
37. Replication of hepatitis B in HBsAg-positive siblings
38. LONG-TERM OUTCOME FOLLOWING SPONTANEOUS HBEAG SEROCONVERSION IN PATIENTS WITH CHRONIC HEPATITIS B
39. Prednisolone modulates the therapeutic effect of interferon to eliminate preferentially the hepatitis B virus precore stop mutant
40. Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma
41. Amino acid substitutions in codons 9-11 of hepatitis C virus core protein lead to the synthesis of a short core protein product
42. Letter to the Editor: Age at Hepatitis B e Antigen Seroconversion and Other Factors for Outcomes of Chronic Hepatitis B
43. Progression of the proportion of hepatitis B virus precore stop mutant following acute superinfection of hepatitis C
44. Natural history of chronic hepatitis B virus infection: An immunopathological study
45. Acute exacerbations in chronic hepatitis C: a clinicopathological and prognostic study
46. Altered expression patterns of lipid metabolism genes in an animal model of HCV core-related, nonobese, modest hepatic steatosis
47. Severe clinical rebound upon withdrawal of corticosteroid before interferon therapy: Incidence and risk factors
48. Purification and Characterization of a Naturally Processed Hepatitis B Virus Peptide Recognized by CD8 sup plus Cytotoxic T Lymphocytes
49. Hepatitis C virus infection in patients with chronic liver diseases in an endemic area for hepatitis B virus infection
50. Prognosis of immune-tolerant phase chronic hepatitis B
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.